These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17337289)

  • 21. Polycystic ovary syndrome is associated with elevated plasma soluble CD40 ligand, a marker of coronary artery disease.
    Oktem M; Ozcimen EE; Uckuyu A; Esinler I; Pamuk B; Bayraktar N; Kulaksizoglu S; Zeyneloglu HB
    Fertil Steril; 2009 Jun; 91(6):2545-50. PubMed ID: 18554599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Measurement peripheral blood index related to inflammation and ox-LDL, ox-LDLAb in patients with coronary heart disease and its clinical significance].
    Zhou ZX; Qiang H; Ma AQ; Chen H; Zhou P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):258-62. PubMed ID: 16706128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased plasma concentrations of soluble CD40 ligand in acute coronary syndrome depend on in vitro platelet activation.
    Ivandic BT; Spanuth E; Haase D; Lestin HG; Katus HA
    Clin Chem; 2007 Jul; 53(7):1231-4. PubMed ID: 17495016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation.
    Ferro D; Loffredo L; Polimeni L; Fimognari F; Villari P; Pignatelli P; Fuster V; Violi F
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2763-8. PubMed ID: 17901373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical implications of increased expression of CD40L in patients with acute coronary syndromes.
    Yan J; Wu Z; Huang Z; Li L; Zhong R; Kong X
    Chin Med J (Engl); 2002 Apr; 115(4):491-3. PubMed ID: 12133281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients.
    Vivona N; Bivona G; Noto D; Sasso BL; Cefalù AB; Chiarello G; Falletta A; Ciaccio M; Averna MR
    Clin Biochem; 2009 Nov; 42(16-17):1713-8. PubMed ID: 19732763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diurnal variation of soluble CD40 ligand in patients with acute coronary syndrome. Soluble CD40 ligand and diurnal variation.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC
    Thromb Res; 2009 Feb; 123(4):617-21. PubMed ID: 18579184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated circulating soluble CD40 ligand in patients with mixed connective tissue disease.
    Jinnin M; Ihn H; Yazawa N; Asano Y; Yamane K; Tamaki K
    Clin Rheumatol; 2003 Feb; 22(1):37-9. PubMed ID: 12605316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of soluble CD40 ligand at flare and at remission in patients with systemic lupus erythematosus.
    Urquizu-Padilla M; Balada E; Cortés F; Pérez EH; Vilardell-Tarrés M; Ordi-Ros J
    J Rheumatol; 2009 May; 36(5):953-60. PubMed ID: 19332622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between serum levels of soluble CD40/CD40 ligand and organ damage in hypertensive patients.
    Yuan M; Ohishi M; Wang L; Raguki H; Wang H; Tao L; Ren J
    Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):848-51. PubMed ID: 20456428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of genetic polymorphisms in oxidative stress related genes and smoking on plasma MDA-LDL, soluble CD40 ligand, E-selectin and soluble ICAM1 levels in patients with coronary artery disease.
    Ueno T; Watanabe H; Fukuda N; Tsunemi A; Tahira K; Matsumoto T; Takayama T; Chiku M; Saito S; Sato Y; Hirayama A; Matsumoto K; Soma M
    Med Sci Monit; 2009 Jul; 15(7):CR341-8. PubMed ID: 19564823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillation.
    Duygu H; Barisik V; Kurt H; Turk U; Ercan E; Kose S
    Europace; 2008 Feb; 10(2):210-4. PubMed ID: 18184662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble CD40 ligand and atrial fibrillation: relationship to platelet activation, and endothelial damage/dysfunction.
    Blann AD; Choudhury A; Freestone B; Patel J; Lip GY
    Int J Cardiol; 2008 Jun; 127(1):135-7. PubMed ID: 17555832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased concentrations of soluble CD40 ligand may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria.
    Chiarelli F; Giannini C; Verrotti A; Mezzetti A; Mohn A
    Diabetes Metab Res Rev; 2008 Oct; 24(7):570-6. PubMed ID: 18756582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response.
    Mysliwiec J; Oklota M; Nikolajuk A; Waligorski D; Gorska M
    Immunol Invest; 2007; 36(3):247-57. PubMed ID: 17558708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between soluble CD40 ligand and gamma-glutamyltransferase concentrations in non-drinking, young Type 1 diabetic individuals.
    Zoppini G; Targher G; Trombetta M; Lippi G; Muggeo M
    Diabet Med; 2008 Nov; 25(11):1283-8. PubMed ID: 19046217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased plasma soluble CD40 ligand concentrations in systemic sclerosis and association with pulmonary arterial hypertension and digital ulcers.
    Allanore Y; Borderie D; Meune C; Lemaréchal H; Weber S; Ekindjian OG; Kahan A
    Ann Rheum Dis; 2005 Mar; 64(3):481-3. PubMed ID: 15708899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis.
    Boos CJ; Balakrishnan B; Blann AD; Lip GY
    J Thromb Haemost; 2008 Nov; 6(11):1841-50. PubMed ID: 18761720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
    Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
    J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes.
    Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B
    Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.